15 charities have expressed concerns at the future of approving cancer drugs in England. In an open letter to Prime Minister David Cameron, representatives from numerous charities stated that it would now be difficult for many drugs to be approved for use in England. Changes will affect the Cancer Drugs Fund, which is a financial pot […]
A breast cancer drug known for extending lives will not be routinely available on the NHS because it is too expensive. NICE (National Institute of Health Care and Excellence) has confirmed that Kadcyla, a drug able to extend life expectancy by around six months in patients with incurable breast cancer, will not be available for all suitable candidates in […]